Navigation Links
Moderate alcohol consumption in middle age can lower cardiac risk
Date:3/7/2008

New York, March 7, 2008 Previous studies have pointed out the benefits of moderate alcohol consumption as a factor in lowering cardiovascular risk. In a study conducted by the Department of Family Medicine at the Medical University of South Carolina and published in the March 2008 issue of The American Journal of Medicine, researchers found that middle-aged non-drinkers who began consuming moderate amounts of alcohol saw an immediate benefit of lower cardiac disease morbidity with no change in mortality after four years.

Studying 7,697 people between 45 and 64 who were non-drinkers and who were participating in the Atherosclerosis Risk in Communities (ARIC) study over a 10 year period, the authors found that 6% began moderate alcohol consumption (1 drink per day or fewer for women and 2 drinks per day or fewer for men) during the follow-up period. After 4 years of follow-up, new moderate drinkers had a 38% lower chance of developing cardiovascular disease than did their non-drinking counterparts. Even after adjusting for physical activity, Body Mass Index, demographic and cardiac risk factors, this difference persisted.

The study also identified a subset of new drinkers who consumed only wine. When comparing non-drinkers to wine-only drinkers, drinkers of other types of alcohol, and heavy drinkers, the wine-only drinkers had the most significant reduction in cardiovascular events. Drinkers of other types of alcohol also had an advantage over non-drinkers, but the difference did not reach statistical significance.

Writing in the article, Dana E. King, MD, MS, states, A substantial cardiovascular benefit from adopting moderate alcohol drinking in middle age appears supported by the current study. Any such benefit must be weighed with caution against the known ill consequences of alcohol consumption. While caution is clearly warranted, the current study demonstrated that new moderate drinking lowers the risk of cardiovascular disease without an increase in mortality in a four-year follow up period. The findings suggest that, for carefully selected individuals, a heart healthy diet may include limited alcohol consumption even among individuals who have not included alcohol previously.


'/>"/>

Contact: Pamela Poppalardo
ajmmedia@elsevier.com
212-633-3944
Elsevier Health Sciences
Source:Eurekalert

Related medicine news :

1. A Drug With Efficacy Superior to That of Memantine Would Earn up to a 50% Patient Share in the Moderate-to-Severe Alzheimers Disease Drug Market
2. Moderate Aerobic Fitness Levels May Cut Stroke Risk
3. Gene variant linked to moderated symptoms of beta-thalassemia
4. Moderate Exercise Cuts Risk of Metabolic Syndrome
5. New Study Demonstrates Ramelteon Does Not Exacerbate Respiratory Depressant Effects in Patients With Moderate-to-Severe COPD
6. Research Shows Alcohol Can Benefit the Hearts of New Drinkers
7. U of Minn researchers find primary alcohol prevention programs are needed for tweens
8. Alcoholics underestimate the risk of bleeding
9. Gene variant predicts medication response in patients with alcohol dependence
10. Eye Blinks May ID Fetal Alcohol Exposure
11. Parental Drinking Boosts Teen Alcohol Risks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... April 29, 2016 , ... Jvion, the ... of funding led by Eastside Partners, with participation from existing investor Martin Ventures. ... base and accelerate its technology and product roadmap. , “Jvion is ...
(Date:4/29/2016)... ... 2016 , ... CURE Media Group , the nation’s ... today announced that Lynne Malestic, RN, of Eisenhower Lucy Curci Cancer Center in ... Oncology Nursing , which honors nurses who have dedicated their careers to helping ...
(Date:4/29/2016)... ... April 29, 2016 , ... Natren, Inc. ... line of probiotics, Petbiotics ™, as they fondly call them. As animal ... groups networking for their non-profit organizations. Animal rescues across the nation face huge ...
(Date:4/29/2016)... (PRWEB) , ... April 29, 2016 , ... ... raising awareness for Duchenne muscular dystrophy, and funding for Duchenne research, participated in ... efficacy of the Sarepta Therapeutic’s novel Duchenne drug eteplirsen. The meeting at the ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... 2014. Each year, reproductive endocrinologists are required to report in vitro fertilization ... of professionals dedicated to the practice of assisted reproductive technologies in the United ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... , April 28, 2016 ... H1 2016" is a report that provides an ... strengthen R&D pipelines by identifying new targets and ... Company Profiles discussed in this H1 2016 ... Riunite Srl, AbbVie Inc., Abiogen Pharma S.p.A., Ablynx ...
(Date:4/27/2016)... le 27 Avril 2016 ... progressé de +5% sur le trimestre, soutenu par ... consommables  Croissance de +16% des ventes ... Mauna Kea Technologies (Euronext : MKEA, FR0010609263 ; OTCQX : ... laser, annonce aujourd,hui son chiffre d,affaires pour le ...
(Date:4/27/2016)... 27, 2016 Transparency Market Research ... Market - Global Industry Analysis, Size, Share, Growth, Trends, ... the global skincare devices market was valued at US$ ... at a CAGR of 10.1% from 2015 to 2023 ... Browse the full Skincare Devices Market (Treatment Device - LED ...
Breaking Medicine Technology: